Anterix INC Form 4 insider transactions

Ryan Gerbrandt, Chief Operating Officer of Anterix Inc., disposed of shares to cover withholding tax obligations related to the vesting of restricted stock units.

Gena L. Ashe, Chief Legal Officer & Corp Sec of Anterix Inc., disposed of shares to cover withholding obligations related to the vesting of restricted stock units.

Director William Heard reports multiple disposals of Anterix Inc. common stock through Heard Capital LLC between February and March 2025.

Director William Heard reports acquisition of 1,887 shares of Anterix Inc. common stock and indirect ownership of 1,741,989 shares through Heard Capital LLC.

An amended SEC Form 4 filing reveals a correction to the expiration date of stock options granted to Anterix Inc.'s President and CEO, Scott A. Lang.

Thomas R. Kuhn, a director and Chairman of Anterix Inc., reports the acquisition of stock options exercisable for 56,803 shares of common stock.

Anterix CEO Scott Lang was granted 191,326 stock options on January 17, 2025, which vest over three years.

Anterix Inc.'s Chief Regulatory and Communications Officer, Christopher Guttman-McCabe, was granted stock options for 67,774 shares on January 16, 2025.

Anterix Inc.'s Chief Legal Officer, Gena L. Ashe, was granted stock options for 37,275 shares, vesting over three years starting January 16, 2025.

Anterix's Chief Financial Officer, Timothy Gray, was granted 40,664 stock options on January 16, 2025, which vest over three years.

Anterix Inc.'s Chief Operating Officer, Ryan Gerbrandt, was granted stock options for 67,774 shares, vesting over three years starting January 16, 2025.

Anterix Inc. filed an amended Form 4 to correct a previously reported stock option grant to director Thomas R. Kuhn, reducing it from 61,804 to 7,108 shares.

Thomas R. Kuhn, Vice Chairman of Anterix Inc., reports the acquisition of stock options in a recent SEC Form 4 filing.

Anterix Inc. Vice Chairman Thomas R. Kuhn amended a previous SEC Form 4 filing to correct the number of restricted stock shares granted.

Anterix's Executive Chairman, Morgan E. O'Brien, sold 13,609 shares of common stock at an average price of $33.44 on December 16, 2024.

Anterix Inc.'s Executive Chairman, Morgan E. O'Brien, exercised stock options and sold shares on December 9, 2024.

Director Jeffrey Altman of Anterix Inc. reports acquisition of restricted stock awards and adjustments to previously reported direct holdings.

Director Mark Fleischhauer of Anterix Inc. acquired 3,500 common shares and 5,002 restricted shares on December 5, 2024.

Anterix Inc. Vice Chairman Thomas R. Kuhn acquired 6,574 shares of common stock through a restricted stock award.

Director Leslie B. Daniels of Anterix Inc. reported acquiring 5,002 shares of common stock and holding 7,000 shares indirectly through an IRA and 401K.

Director Mahvash Yazdi acquired 5,002 shares of Anterix Inc. stock and reported indirect holdings through a family trust and 401(k).

Anterix director Leslie B. Daniels acquired 2,000 shares of common stock through an IRA on November 20, 2024.

Gena L. Ashe, Chief Legal Officer of Anterix Inc., sold 5,547 shares of common stock at $33 per share on November 19, 2024.

Anterix Inc.'s Chief Regulatory and Communications Officer, Christopher Guttman-McCabe, sold 3,447 shares of common stock to cover tax obligations related to vesting restricted stock units.

Anterix Inc.'s Chief Financial Officer, Timothy Gray, acquired stock options for 30,731 shares on October 4, 2024.

Gena L. Ashe, Chief Legal Officer & Corp Sec of Anterix Inc., reports the acquisition of stock options.

Ryan Gerbrandt, Chief Operating Officer of Anterix Inc., reports the acquisition of stock options.

Anterix Inc. CEO Robert Harris Schwartz disposed of 6,355 shares of common stock on August 23, 2024, to cover withholding obligations related to the vesting of restricted stock units.

Christopher Guttman-McCabe, Chief Regulatory & Communications Officer of Anterix Inc., acquired 85,000 stock options after shareholders approved an amendment to the company's 2023 Stock Plan.

Ryan Gerbrandt, Chief Operating Officer of Anterix Inc., reports the withholding of 1,479 common stock shares to cover tax obligations related to vesting restricted stock units on July 12, 2024.